Evidence map›Paper›PMID 35084112›Full record

ArticleMicrobial biotechnology2022

The potential of bacteriophages to control Xanthomonas campestris pv. campestris at different stages of disease development.

Dominique Holtappels, Kiandro J Fortuna, Lauren Moons, Nand Broeckaert, Léon E Bäcker, Sofie Venneman, Sofie Rombouts, Louis Lippens, Steve Baeyen, Sabien Pollet and 8 more

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Efficacy ofMicrobiology spectrum · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Viruses · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 4 countries.

Dominique HoltappelsLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.ORCID 0000-0003-4263-3407
Kiandro J FortunaLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Lauren MoonsLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Nand BroeckaertLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Léon E BäckerLaboratory of Food Microbiology, KU Leuven, Leuven, Belgium.
Sofie VennemanProefstation voor de groenteteelt, Sint-Katelijne-Waver, Belgium.
Sofie RomboutsLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Louis LippensProvinciaal Proefcentrum voor de Groenteteelt Oost-Vlaanderen, Kruishoutem, Belgium.
Steve BaeyenFlanders Research Institute for Agriculture, Fisheries and Food, Ghent, Belgium.
Sabien PolletInagro, Beitem, Belgium.
Jean-Paul NobenBiomedical Research Institute and Transnational University Limburg, Hasselt University, Hasselt, Belgium.
Frank OechslinDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Marta VallinoInstitute for Sustainable Plant Protection, National Research Counsil of Italy, Turin, Italy.
Abram AertsenLaboratory of Food Microbiology, KU Leuven, Leuven, Belgium.
Martine MaesIndependent Researcher, Ghent, Belgium.
Johan Van VaerenberghFlanders Research Institute for Agriculture, Fisheries and Food, Ghent, Belgium.
Rob LavigneLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Jeroen WagemansLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
KU Leuven · BEVlaams Instituut voor Biotechnologie · BEVIB-KU Leuven Center for Microbiology · BEInagro (Belgium) · BEInstitute for Sustainable Plant Protection · ITProstate Cancer Foundation · USRode Kruis-Vlaanderen · BETransnational University Limburg · BEUniversity College Ghent · BEUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xanthomonas campestris pv. campestris (Xcc) is a vascular pathogen that invades the xylem of Brassica crops. Current chemical and antibiotics-based control measures for this bacterium are unsustainable and inefficient. After establishing a representative collection of Xcc strains, we isolated and characterized bacteriophages from two clades of phages to assess their potential in phage-based biocontrol. The most promising phages, FoX2 and FoX6, specifically recognize (lipo) polysaccharides, associated with the wxc gene cluster, on the surface of the bacterial cell wall. Next, we determined and optimized the applicability of FoX2 and FoX6 in an array of complementary bioassays, ranging from seed decontamination to irrigation- and spray-based applications. Here, an irrigation-based application showed promising results. In a final proof-of-concept, a CaCl

Indexed as

BacteriophagesBrassicaXanthomonas campestrisMultigene FamilyPlant Diseases

Identifiers

PMID35084112
PMCPMC9151335
OpenAlexW4210547408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.